<< CSR 1975-2010 Home

The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.10

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 30-34

Both Sexes
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 60,192 84.8 0.9* 17,718 90.1 1.3*
1. Leukemias 2,001 2.8 0.5 610 3.1 0.5
2. Lymphomas 6,631 9.3 1.7* 1,850 9.4 1.3
3. CNS, intracranial, intraspinal 2,386 3.4 0.4 683 3.5 0.4
4. Osseous & chondromatous nepolasms 450 0.6 0.7 136 0.7 0.7
5. Soft tissue sarcomas 4,973 7.0 1.4 752 3.8 -0.6
6. Germ cell and trophoblastic neoplasms 4,996 7.0 1.8* 1,568 8.0 0.5
7. Melanoma and skin carcinomas 7,673 10.8 1.5* 2,352 12.0 -0.1
8. Carcinomas (excluding skin) 30,154 42.5 0.6* 9,451 48.0 2.0*
9. Miscellaneous specified neoplasms, NOS 631 0.9 1.6* 222 1.1 1.6*
10. Unspecified malignant neoplasms 296 0.4 1.1 93 0.5 1.1
Males
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 25,085 70.7 1.0* 6,733 68.1 1.0*
1. Leukemias 1,158 3.3 0.6* 347 3.5 0.6*
2. Lymphomas 4,132 11.6 1.9* 1,064 10.8 2.5
3. CNS, intracranial, intraspinal 1,390 3.9 0.3 391 4.0 0.3
4. Osseous & chondromatous nepolasms 246 0.7 0.4 70 0.7 0.4
5. Soft tissue sarcomas 4,023 11.3 1.4 475 4.8 -2.5
6. Germ cell and trophoblastic neoplasms 4,668 13.2 1.9* 1,471 14.9 0.5
7. Melanoma and skin carcinomas 3,090 8.7 0.1 891 9.0 0.1
8. Carcinomas (excluding skin) 6,023 17.0 0.7* 1,891 19.1 3.0*
9. Miscellaneous specified neoplasms, NOS 252 0.7 2.5* 101 1.0 2.5*
10. Unspecified malignant neoplasms 103 0.3 - 32 0.3 -
Females
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 35,107 99.0 0.7* 10,985 112.3 1.5*
1. Leukemias 843 2.4 0.3 263 2.7 0.3
2. Lymphomas 2,499 7.0 1.4* 786 8.0 1.4*
3. CNS, intracranial, intraspinal 996 2.8 0.5 292 3.0 0.5
4. Osseous & chondromatous nepolasms 204 0.6 - 66 0.7 -
5. Soft tissue sarcomas 950 2.7 0.4 277 2.8 0.4
6. Germ cell and trophoblastic neoplasms 328 0.9 0.3 97 1.0 0.3
7. Melanoma and skin carcinomas 4,583 12.9 2.2* 1,461 14.9 1.0*
8. Carcinomas (excluding skin) 24,131 68.1 0.6* 7,560 77.3 1.9*
9. Miscellaneous specified neoplasms, NOS 379 1.1 1.1 121 1.2 1.1
10. Unspecified malignant neoplasms 193 0.5 - 61 0.6 -

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2010.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.